Literature DB >> 21146792

A review of hyaluronan and its ophthalmic applications.

Marjorie J Rah1.   

Abstract

Hyaluronan (HA) is a naturally occurring, biocompatible polysaccharide with unique viscoelastic and hygroscopic properties. Its role as a natural lubricant and its excellent water-retaining properties make it well-suited for use in ophthalmic products. Many reports have been written describing the various uses of HA. The purpose of this report is to review the uses of HA in the anterior segment of the eye, more specifically, its use in the treatment of dry eye syndrome, and in contact lenses and contact lens care systems.
Copyright © 2011 American Optometric Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21146792     DOI: 10.1016/j.optm.2010.08.003

Source DB:  PubMed          Journal:  Optometry        ISSN: 1558-1527


  27 in total

Review 1.  An introduction to proteoglycans and their localization.

Authors:  John R Couchman; Csilla A Pataki
Journal:  J Histochem Cytochem       Date:  2012-09-26       Impact factor: 2.479

2.  Functionalized Hyaluronic Acid for "In Situ" Matrix Metalloproteinase Inhibition: A Bioactive Material to Treat the Dry Eye Sydrome.

Authors:  Susi Burgalassi; Marco Fragai; Oscar Francesconi; Linda Cerofolini; Daniela Monti; Gemma Leone; Stefania Lamponi; Giuseppe Greco; Agnese Magnani; Cristina Nativi
Journal:  ACS Macro Lett       Date:  2022-09-14       Impact factor: 7.015

Review 3.  Principles of pharmacology in the eye.

Authors:  Sahar Awwad; Abeer H A Mohamed Ahmed; Garima Sharma; Jacob S Heng; Peng T Khaw; Steve Brocchini; Alastair Lockwood
Journal:  Br J Pharmacol       Date:  2017-10-10       Impact factor: 8.739

4.  Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study.

Authors:  Huba J Kiss; János Németh
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

5.  A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome.

Authors:  Juan Carlos Pinto-Bonilla; Alberto Del Olmo-Jimeno; Fernando Llovet-Osuna; Emiliano Hernández-Galilea
Journal:  Ther Clin Risk Manag       Date:  2015-04-13       Impact factor: 2.423

6.  Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK.

Authors:  Yuri S Astakhov; Sergei Y Astakhov; Alla B Lisochkina
Journal:  Clin Ophthalmol       Date:  2013-12-09

7.  Visualization of a hyaluronan network on the surface of silicone-hydrogel materials.

Authors:  Katarzyna A Wygladacz; Daniel J Hook
Journal:  Clin Ophthalmol       Date:  2016-07-28

8.  A Crosslinked HA-Based Hydrogel Ameliorates Dry Eye Symptoms in Dogs.

Authors:  David L Williams; Brenda K Mann
Journal:  Int J Biomater       Date:  2013-06-06

9.  Efficacy of a crosslinked hyaluronic acid-based hydrogel as a tear film supplement: a masked controlled study.

Authors:  David L Williams; Brenda K Mann
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

10.  Hyaluronate Acid-Dependent Protection and Enhanced Corneal Wound Healing against Oxidative Damage in Corneal Epithelial Cells.

Authors:  Jing Zhong; Yuqing Deng; Bishan Tian; Bowen Wang; Yifang Sun; Haixiang Huang; Ling Chen; Shiqi Ling; Jin Yuan
Journal:  J Ophthalmol       Date:  2016-04-14       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.